搜索筛选:
搜索耗时4.6141秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[会议论文] 作者：Jihong Liu,Chunyan Lan,Xin Huang,Suxia Lin,Huiqiang Huang,Qichun Cai,Jiabin Lu,
来源：第十三次全国妇科肿瘤学术会议 年份：2012
...
[会议论文] 作者：Jihong Liu,Chunyan Lan,Xin Huang,Suxia Lin,Huiqiang Huang,Qichun Cai,Jiabin Lu,
来源：第十三次全国妇科肿瘤学术会议 年份：2012
Objectiyes Interleukin(IL)-17 is the signature cytokine of T helper 17 cells.The role of IL-17 in the tumor microenvironment is still controversial.Few studies describing IL-17 expression in ovarian c...
[会议论文] 作者：Guimiao Lin,Wenqi Jiang,Marie C.M.Lin,Suxia Lin,Hong Yao,Wanxian Yi,Samuel S.M.Ng,Xiaomei Wang,
来源：2012医学科学前沿暨第二届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份：2012
hTERTC27,a 27 kDa C-terminal polypeptide,can induce telomere dysfunction and inhibit tumor cell proliferation.To study the synergistic anti-tumor effects of hTERTC27 polypeptide driven by Egr-1 promot...
[期刊论文] 作者：Min Luo,Yuhui Xia,Fang Wang,Hong Zhang,Danting Su,Chaoyue Su,Chuan Yang,Shaocong Wu,Sainan An,Suxia Lin,
来源：药学学报（英文版） 年份：2021
ERK pathway regulated the programmed death ligand-1 (PD-L1) expression which was linked to the response of programmed death-1 (PD-1)/PD-L1 blockade therapy.So it is deducible that ERK inhibitor could enhance the efficacy of PD-1 inhibitor i......
[期刊论文] 作者：Meifang Xu,Fei Wang,Hong Chen,Lin Liu,Wenwen Liu,Yinghong Yang,Qiaoling Zheng,Lihong Zhang,Xiaoxuan Li,Suxia Lin,
来源：癌症生物学与医学（英文版） 年份：2019
Objective: Angioimmunoblastic T cell lymphoma (AITL) is an aggressive form of non-Hodgkin lymphoma derived from mature T cells. However, the underlying pathogen...
相关搜索：
